## HUM: Humana Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.00 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($247.09)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. California Public Employees Retirement System Has $53.27 Million Stock Holdings in Humana Inc. $HUM**
- Source: MarketBeat | 20251210T095938 | Somewhat-Bullish | Relevance: 99%
-  The California Public Employees Retirement System increased its stake in Humana Inc. (NYSE:HUM) by 11.9% to 217,875 shares, valued at approximately $53.27 million. Other institutional investors also made significant moves, contributing to 92.38% institutional ownership. Analysts currently have a "Hold" rating on Humana with a consensus target price of $296.84.

**2. Amundi Sells 7,355 Shares of Humana Inc. $HUM**
- Source: MarketBeat | 20251209T000812 | Neutral | Relevance: 99%
-  Amundi reduced its stake in Humana Inc. by 1.9%, selling 7,355 shares and retaining 387,288 shares valued at approximately $94.42 million. Despite this, institutional ownership remains high at 92.38%, with other funds increasing their positions. Analysts have a mixed view with a consensus "Hold" rating and an average target price of $296.84 for Humana.

**3. Humana Healthy Horizons in Oklahoma (NYSE: HUM) funds six nonprofits with $295,500**
- Source: Stock Titan | 20251210T161304 | Somewhat-Bullish | Relevance: 99%
-  Humana Healthy Horizons in Oklahoma has awarded $295,500 in Community Impact Awards to six non-profit organizations. These funds will be used to address critical health-related social needs across Oklahoma, such as "Food as Medicine" programs, stable housing access, and employment opportunities. The initiative aligns with Oklahoma's health priorities and aims to support Humana's Medicaid population in the state, particularly addressing financial strain and food insecurity among members.

**4. Ardsley Advisory Partners LP Acquires Shares of 50,000 Humana Inc. $HUM**
- Source: MarketBeat | 20251210T090857 | Somewhat-Bullish | Relevance: 98%
-  Ardsley Advisory Partners LP has acquired 50,000 shares of Humana Inc. (NYSE:HUM) stock, valued at approximately $12.22 million, making it their 13th largest holding. Other institutional investors have also adjusted their positions in Humana, with a significant 92.38% of the company's stock owned by institutional investors and hedge funds. Humana recently announced a quarterly dividend of $0.885 per share and reported earnings per share of $3.24, exceeding analyst estimates.

**5. Humana Inc. $HUM Stake Lifted by Investment Management Corp of Ontario**
- Source: MarketBeat | 20251211T122809 | Somewhat-Bullish | Relevance: 98%
-  Investment Management Corp of Ontario significantly increased its stake in Humana Inc. (NYSE:HUM) by 205.5% in the second quarter, now holding 10,375 shares valued at $2,536,000. Several other institutional investors also modified their holdings, with 92.38% of the stock owned by institutional investors and hedge funds. Humana reported strong quarterly earnings and revenue, and announced a quarterly dividend of $0.885 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Jefferies | $313 | $253 | +24% |
| 2025-11-25 | Barclays | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Jefferies | up | Buy |
| 2025-11-25 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-0.3%)
- Dodge & Cox Inc.: 9.4% (-0.1%)
- JPMORGAN CHASE & CO: 8.4% (+237.0%)
- Blackrock Inc.: 8.3% (-3.0%)
- State Street Corpora: 4.5% (-0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +2.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.00 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.0x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.1B |
| Beta | 0.47 |
| 52W Range | $206.87 - $315.35 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 21.1 |
| Current P/E | 15.6 |
| YoY Growth | -26.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 4.9% to 7.3% (+2.4% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 3.5% confirms short-term momentum alignment. AM_20 at 9.6% shows strong absolute momentum above own 20MA. Outperforming sector by 9.7pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.85), confirming momentum. RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.35% (CS: 88) | Strong |
| RSI_14 | 60.0 | Neutral |
| MACD Histogram | 3.85 | Bullish |
| vs SMA20 | 1.096x | Above |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 1.030x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $266.49
- **Stop Loss:** $247.09 (7.3% risk)
- **Target:** $305.29 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 71
- **Position Value:** $18,920.79
- **Portfolio %:** 18.92%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $-3.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.24 | +14.6% |
| 2025Q2 | $5.87 | $6.27 | +6.9% |
| 2025Q1 | $10.07 | $11.58 | +15.0% |
| 2024Q4 | $-2.12 | $-2.16 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*